Kathryn Choon Beng Tan

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Testosterone Selectively Reduces the High Molecular Weight Form of Adiponectin by Inhibiting Its Secretion from Adipocytes

Aimin Xu, Kok Weng Chan, Ruby L.C. Hoo et al. · Journal of Biological Chemistry · 2005 · 419 citations · Full text

Insulin Signaling, Obesity, Metabolic Syndrome +16

Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation

Kathryn Choon Beng Tan, Aimin Xu, Wing-Sun Chow et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 358 citations · Full text

Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes

Kathryn Choon Beng Tan, Wing-Sun Chow, Victor Ai et al. · Diabetes Care · 2002 · 309 citations · Full text